Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6184779 | Gynecologic Oncology | 2011 | 4 Pages |
Abstract
⺠HA-CMC use for adhesion prevention during surgery for ovarian cancer does not increase morbidity. ⺠HA-CMC is not associated with major postoperative surgical complications. ⺠HA-CMC use may increase the risk of pelvic abscess under certain circumstances.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Lauren S. Krill, Stefanie M. Ueda, Melissa Gerardi, Robert E. Bristow,